Board-Certified MD | Hospitalist & ER Expert

Specialties & Experience of this Expert Witness

Additional Information

Dr. Ayman Elbatanony, MD, MBA is a board-certified internal medicine physician with extensive experience in high-acuity and rural healthcare settings. He completed medical school in both Egypt and the United States, bringing a unique dual perspective to clinical practice. He has nearly four years of rural medicine experience, including emergency department and critical access hospital coverage, and two years as a dedicated hospitalist. His clinical background encompasses acute care, cardiology-focused medicine, and complex case management across emergency, inpatient, and outpatient environments. Dr. Elbatanony has been retained in a defense case, authoring a detailed, evidence-based expert report that was accepted in full by counsel. His reports are prepared to litigation standards—clear, scientifically rigorous, and defensible under cross-examination. While he has not yet testified at deposition or trial, he is known for being highly responsive, available, and able to translate complex medical issues into plain, persuasive language for attorneys and juries alike. His areas of expertise include standards of care in hospital medicine, rural emergency care, critical access facilities, and internal medicine. He is well-versed in cases involving delayed or missed diagnosis (myocardial infarction, stroke, sepsis, pulmonary embolism, heart failure, DVT/PE), anticoagulation and bleeding complications, medication safety and adverse drug effects, cardiac arrhythmias, obesity-related complications, chest pain evaluation, syncope, respiratory failure, electrolyte disturbances, and hospital-acquired infections. This breadth enables him to analyze and opine on a wide range of medical-legal matters, from primary care and hospitalist cases to emergency and cardiology-related litigation. Academically, Dr. Elbatanony has authored and published multiple abstracts and case reports, including: Ticagrelor-Induced Pneumonitis and Pulmonary Hemorrhage Following STEMI (Society of General Internal Medicine, 2022) – highlighting rare but serious adverse drug reactions in acute coronary syndrome. Think Non-Compaction Cardiomyopathy in CHF with NSVT (SGIM, 2022) – emphasizing recognition of uncommon cardiomyopathies in heart failure. Lp(a), LDL, and Recurrent ACS: A Retrospective Outcome Analysis (Advocate Aurora Health, 2025) – outcomes-focused cardiology research, under review. Morbid Obesity–Related Motion Artifact Mimicking Type A Aortic Dissection (AHA Resuscitation Science Symposium, 2025, under review). Propafenone-Induced Ventricular Arrhythmia in CYP2D6 Slow Metabolizers (under review) – a pharmacogenomics and electrophysiology-focused case report. These publications demonstrate his ability to apply clinical reasoning, evidence-based medicine, and academic rigor to complex cardiology and internal medicine topics. In addition to his clinical and academic work, Dr. Elbatanony is a member of Sigma Sigma Phi Honor Society and Toastmasters International, reflecting his commitment to leadership, professionalism, and excellence in communication. His background in public speaking strengthens his ability to explain technical medical concepts clearly and persuasively to both legal teams and lay audiences. Dr. Elbatanony offers attorneys the combination of broad frontline clinical experience, academic engagement, and the ability to communicate persuasively in both written reports and oral testimony. His practice areas make him particularly valuable for cases involving hospitalist medicine, obesity medicine, rural and emergency care, cardiology, and complex internal medicine issues. He is available for consultation, case review, report preparation, and testimony nationwide.